MVT Biotechnology GmbH
Media Quarter Marx 3.2
We are very pleased to announce our first invention!
Following to our promising Proof of Concept Study, showing an immune response raised in 100% of mice inoculated with the vaccine, MVT Biotechnology has filed for IP protection of a proprietary vaccine construct against the Hepatitis E Virus.
If you want to take part in the forthcoming progress of our company feel free to contact us.
News Alert 12/2016:
The The Austrian Research Promotion Agency (FFG) is the national funding agency for industrial research and development in Austria. As a "one-stop shop" offering a diversified and targeted programme portfolio, the FFG gives Austrian businesses and research facilities quick and uncomplicated access to research funding.
News Alert 10/2016:
MVT Biotechnology receives Start Up Grant from Inits
INiTS is a business incubator designed to improve the rate of startup successin Vienna by helping entrepreneurs conceive, launch and grow the next great company. INiTS ranked as No. 11 worldwide and No. 3 in Europe.
We are excited to announce that MVT Biotechnology has been selected by INiTS for its Startup Camp, the first acceleration program in Austria, offering early-stage startups 100 days of training in order to achieve market fit.